
    
      This study is a double-blind clinical trial. Two hundred subjects has participated in it. The
      study is explained to the subjects, and they voluntarily choose to participate in it. Their
      eligibility to participate in the study is checked, and they are randomized either into the
      intra-articular collagen injection group or the normal saline (placebo) injection group based
      on a randomization table. They are asked to follow the guidelines of the investigators during
      the study and to visit the hospital five times, including for screening. At each visit, the
      subjects will undergo an examination with doctors, a medical examination by interview, and a
      blood test only when it is necessary to evaluate the safety and efficacy of the injection.

      (*If the subjects performed the screening during the first visit on, the total number of his
      or her additional visits is four.)
    
  